ClinicalTrials.Veeva

Menu

Effect of Hyperoxia and Hypergravity on Lung Ventilation and Perfusion

D

Direction Centrale du Service de Santé des Armées

Status

Completed

Conditions

Atelectasis

Treatments

Other: gas mixture
Other: hypergravity

Study type

Interventional

Funder types

Other

Identifiers

NCT01993394
10co706

Details and patient eligibility

About

The primary aim of this project is to get further knowledge on the effects of + Gz accelerations and hyperoxia on lung ventilation in humans. The secondary aim is to study lung perfusion and cardiovascular function in these conditions.

Full description

Experiments were conducted in a human centrifuge. The protocol aimed at mimicking a routine peacetime flight in combat aircraft, and included 10-min exposure to +1.4 - +3.5 Gz. Subjects were exposed three times to this sequence, breathing air, 44.5% O2 or 100% O2.

Ten volunteers wearing anti-G trousers participated in the study. The Ethics Committee Ile-de-France III and the French National Agency for Drug Safety (ANSM) approved the protocol (number 2009-A01092-55).

Three different imaging techniques, electrical impedance tomography (EIT), pulmonary ultrasound and chest SPECT/CT were used and compared. EIT enabled ventilation monitoring in the human centrifuge, whereas pulmonary ultrasound and SPECT/CT gave functional and topographical information before and after exposure to +Gz accelerations. EIT analysis focused on regional ventilation, SPECT on global lung ventilation and perfusion, CT on the presence of atelectasis, and pulmonary ultrasound analysis looked for comet tails in 64 chest areas. Arterial blood pressure was recorded continuously by finger photoplethysmography. Cardiac output and stroke volume were computed from these recordings, using three different algorithms. Echocardiography was used as reference non-invasive technique for stroke volume determination and performed before and after exposure to +Gz accelerations.

Enrollment

20 patients

Sex

Male

Ages

25 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • normal lung function checked by pulmonary function tests

Part 1 exclusion Criteria:

  • past medical history of heart or lung disease
  • current medical treatment for heart or lung disease
  • smoking
  • bad tolerance to +Gz accelerations (G-induced loss of consciousness, motion sickness)

Part 2 exclusion criteria:

  • past medical history of heart or lung disease
  • current medical treatment for heart or lung disease
  • smoking
  • The use of medication for hypertension
  • asymmetric values of left/right humeral arterial blood pressure
  • significant echocardiographic abnormalities or bad echogenicity
  • bad tolerance to +Gz accelerations (G-induced loss of consciousness, motion sickness)

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Single Blind

20 participants in 1 patient group

ventilation
Experimental group
Description:
hypergravity gas mixture
Treatment:
Other: hypergravity
Other: gas mixture

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems